William J. Plovanic - 31 Oct 2025 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Role
Director
Signature
/s/ Megan Smeykal, Attorney-in-Fact
Issuer symbol
TELA
Transactions as of
31 Oct 2025
Transactions value $
$0
Form type
4
Filing time
03 Nov 2025, 16:22:34 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Plovanic William J. Director C/O TELA BIO, INC., 1 GREAT VALLEY PARKWAY, SUITE 24, MAVERN /s/ Megan Smeykal, Attorney-in-Fact 03 Nov 2025 0001685640

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TELA Common Stock Award $0 +11.9K $0.00 11.9K 31 Oct 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TELA Stock Option (Right to Buy) Award $0 +17.6K $0.00 17.6K 31 Oct 2025 Common Stock 17.6K $1.23 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units will vest in three equal annual installments beginning on October 31, 2026, in each case subject to the Reporting Person's continued service through the applicable vesting date.
F2 The option vests in 36 equal monthly installments on each monthly anniversary of October 31, 2025, in each case subject to the Reporting Person's continued service through the applicable vesting date.